Johnson Johnson AbbVie: Paths to Pharma Dominance
Johnson & Johnson and AbbVie report divergent quarterly results, fueling a debate about two paths to pharma dominance...
Ways To Increase Cash Back Earnings
Discover various ways to increase your cash back earnings. Enhance your savings potential with these effective strategies.
24,319 articlesThese Stocks Trade Like Hot Tech Names, but Stay Underradar
A small group of under-the-radar stocks is flashing AI-like growth signals while remaining off the radar of most inve...
AI’s $182 Billion Borrowing Could Be Its Biggest Risk
A record $182 billion in AI-focused bond issuance this year is fueling an infrastructure wave, but investors warn tha...
AMD Stock 320% Over Past Year: Should Investors Shift Focus?
AMD has surged dramatically, up 320% over the past year, sparking questions about whether investors should shift focu...
What It Takes to Earn $8,000 a Month From Dividends
In mid-2026 market conditions test retirement plans built on dividend income. This piece weighs yield versus growth t...
Supercycle Moved Beyond Memory: A Growth Stock Play
The AI boom isn’t just about memory chips anymore. A broader wave of demand is lifting compute, software, and data in...
Oracle Stock Down 60%: Why AI Cloud Growth Makes It a Buy
Oracle stock down 60% from its peak doesn’t tell the whole story. This article digs into the AI cloud momentum fuelin...
What Know About Million-Dollar Bet on Monday.com Amid 75% Drop
A major fund disclosed a $38 million stake in monday.com as the stock collapsed by about 75%. This article explains w...
XYLD Versus SPY: The 28% Price Gap Explained
Investors face a 28% price return gap between XYLD and SPY as income-focused strategy meets growth potential. This re...
Tesla and Nvidia: Both Market Favorites, Yet One Is a Buy
Tesla and Nvidia remain market favorites as AI bets diverge. Analysts say one stock currently offers a clearer, more ...
Tuesday Reads for Investors: A Ten-Topic AM Brief Series
Start your Tuesday with a practical investing briefing. This AM series distills data, trends, and actionable ideas to...
Buy, Sell, Hold: CoreWeave Near $100 Sparks Debate
CoreWeave trades around $100 as a massive backlog tests cash-generation prospects. Q1 results show strong revenue gro...
Popular Topics
Fable
Smart Money Moves For Everyday Life
Investment Strategies In Energy Sector
Best Index Funds For Retirement
Investment Strategies
Untitled D6eff7ea
Crypto For Beginners
Best Dividend Etfs
Index
Innovative Skincare Clinical
Dutch Salary
Blue Owl
Budget
Ai Healthcare News
Penalty Vs No Penalty Depending On Lock Status